Christopher J. Winrow
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Cyclerion (United States)(US)
Publications by Year
Research Areas
Sleep and Wakefulness Research, Sleep and related disorders, Circadian rhythm and melatonin, Photochromic and Fluorescence Chemistry, Regulation of Appetite and Obesity
Most-Cited Works
- → Orexin Receptors: Pharmacology and Therapeutic Opportunities(2011)377 cited
- → Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia(2010)370 cited
- → Distribution of histone deacetylases 1–11 in the rat brain(2007)349 cited
- → Promotion of Sleep by Suvorexant—A Novel Dual Orexin Receptor Antagonist(2011)270 cited
- → Adult mouse brain gene expression patterns bear an embryologic imprint(2005)186 cited
- → Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity(2003)176 cited